Merck Millipore, the Life Science division of Merck KGaA* of Germany, today announced the launch of the innovative Muse™ Cell Analyzer system for real-time quantitative assessment of cell concentration, cell health, apoptosis, and cell cycle with greater accuracy and precision than manual hemocytometry or image-based automated analysis.
Merck Millipore Launches the Muse™ Cell Analyzer, a Breakthrough Solution for Multiparametric Analysis on a Single Platform
By providing real-time, multi-dimensional information on cell populations, the compact Muse™ cell analyzer enables faster, more accurate decision-making, more productive workflows, and is designed to provide a greater insight in to cell health.
The Muse™ system delivers high-performance cell analysis using patent-pending, miniaturized fluorescent detection and microcapillary technology which occupy one-tenth the space of a typical cytometer. Laser-based fluorescence detection of each cell event can evaluate up to three cellular parameters. As a result, Muse™ provides accurate quantitative results compared to imaging-based systems, which only examine up to two parameters, are time-consuming and ultimately provide less quantitative data. The system is capable of analyzing both suspension and adherent cells from two to sixty μm in diameter. Intuitive software and simple touchscreen interface enable rapid set-up and analysis.
“The Muse™ system occupies an important place in our line of cell analysis platforms and delivers unique benefits to researchers,” describes John Sweeney, Head of Life Science Business Field, Merck Millipore. “With Muse™, researchers can gain new insights into cell health with greater precision and accuracy than they have come to experience with existing cell analysis techniques and instruments, without the price barrier as the system is priced just above $12,000.”
To further optimize workflows, the Muse™ Cell Analyzer is designed to work with all-in-one kits, specifically validated for robust performance on the system. Kits include cell count and viability, apoptosis and cell cycle and come with all the reagents necessary for proper sample preparation.
For more information on Muse™ and the full line of cellular analysis platforms from Merck Millipore, please visit the company article page.
Editors at SelectScience attended the launch of the Muse™ Cell Analyzer, and interviewed Katherine Gillis, Research Scientist, EMD Millipore. Look out for the video interview available end Dec on Selectscience.net
Company websiteEMD Millipore, a division of Merck KGaA, Darmstadt, Germany